SCA Prep

Women's Health

Contraception, menstrual problems, menopause, pregnancy-related issues and gynaecological concerns.

Last reviewed

Use this quick reference guide to study and ensure you have mastered these common cases from the curriculum. You can generate specific cases on our SCA cases page or even practice them with our specialised and UK guidelines trained AI Actors.

1Menopause and HRT

Menopause is a clinical diagnosis in women >45 with menopausal symptoms and no periods for 12 months (or 24 months if <50). FSH is not required for diagnosis in this group.

Lifestyle Management

Diet, exercise, weight loss, caffeine/alcohol reduction.

HRT (Systemic)

Uterus present: Combined HRT (Oestrogen + Progestogen).
  • • Sequential: If periods present/irregular (still perimenopausal).
  • • Continuous: If post-menopausal (>1 year no periods).

No Uterus: Oestrogen only.

Route: Transdermal (patch/gel) preferred if BMI >30, risk of VTE, or history of migraine.

Genitourinary Syndrome of Menopause (GSM)

Vaginal Oestrogen (cream/pessary/ring). Safe to use alongside systemic HRT and generally safe in breast cancer history (with specialist advice).

Risks

Small increased risk of breast cancer (combined HRT) and VTE (oral HRT).

2Heavy Menstrual Bleeding (Menorrhagia)

Defined as excessive blood loss interfering with physical, emotional, social, and material quality of life.

Assessment

  • History: Flooding, clots, double protection, impact on life. Check for anaemia symptoms.
  • Examination: Abdominal and pelvic exam (speculum + bimanual) to exclude fibroids/polyps.

Management (if no pathology/fibroids <3cm)

  • Levonorgestrel Intrauterine System (LNG-IUS e.g., Mirena): First-line treatment. Reduces bleeding significantly.
  • Non-hormonal: Tranexamic Acid (1g TDS during bleeding) +/- Mefenamic Acid (500mg TDS for pain).
  • Hormonal: Combined Oral Contraceptive Pill (COCP) or Cyclical Oral Progestogens.

Referral

If fibroids >3cm, compression symptoms, or medical management fails.

3Contraception: UKMEC and Missed Pills

Use the UK Medical Eligibility Criteria (UKMEC) to determine safety.

UKMEC Categories

  • 1: No restriction.
  • 2: Advantages outweigh risks.
  • 3: Risks outweigh advantages (specialist/clinical judgement required).
  • 4: Unacceptable health risk (Contraindicated).

Key Contraindications (UKMEC 3/4 for COCP)

Migraine with aura, BMI ≥35, Breastfeeding <6 weeks postpartum, uncontrolled hypertension, history of VTE/Stroke, age >35 and smoker (>15/day).

Missed Pills (Combined)

  • 1 pill: Take as soon as remembered. No extra protection needed.
  • 2+ pills (active): Take most recent pill, leave others. Use condoms for 7 days. If in week 1 (and unprotected sex occurred) → Emergency Contraception. If in week 3 → Omit pill-free interval (run packs together).

4Endometriosis and Chronic Pelvic Pain

Chronic condition where endometrial-like tissue grows outside the uterus.

Visual explanation

Endometriosis: tissue outside the uterus

Matching frontal uterine cutaways. The first shows the endometrium lining the uterine cavity. The second also shows separate endometriotic patches outside the uterus, on an ovary and on nearby pelvic tissue.

Endometrium

The lining is normally inside the uterine cavity.

Endometriosis

Tissue similar to the lining grows outside the uterus, including on pelvic surfaces and ovaries.

Remember: The location helps explain pelvic pain and possible bowel or bladder symptoms. A normal ultrasound does not exclude endometriosis.

Simplified illustration, not to scale. Sources: NHS: endometriosis · NICE NG73: diagnosis

Symptoms

Cyclical pelvic pain, deep dyspareunia (pain on deep penetration), dysmenorrhoea, dyschezia (pain on opening bowels).

Investigation

Transvaginal Ultrasound (TVUS). Note: A normal scan does not exclude endometriosis.

Management

  • Analgesia: Paracetamol/NSAIDs.
  • Hormonal (Suppress ovulation): COCP (tricycled/continuous), POP, or Mirena IUS.
  • Referral: If symptoms persist despite primary care management, or if deep endometriosis/endometrioma suspected. Gold standard diagnosis is Laparoscopy.

5Cervical Screening and HPV

The programme invites women aged 25-64.

Protocol

High-Risk HPV (hrHPV) is the primary test.

  • hrHPV Negative: Return to routine recall (3 years if 25-49, 5 years if 50-64).
  • hrHPV Positive + Cytology Normal: Repeat test in 12 months.
  • hrHPV Positive + Cytology Abnormal (Dyskaryosis): Refer for Colposcopy.

Red Flags

Post-coital bleeding (PCB), intermenstrual bleeding (IMB), or persistent vaginal discharge require speculum examination. Suspect Cervical Cancer even with normal smear history.

6Polycystic Ovary Syndrome (PCOS) and Amenorrhoea

Common cause of oligomenorrhoea/amenorrhoea and subfertility.

Rotterdam Criteria (2 out of 3)

  • • Oligo/Anovulation (irregular/infrequent periods).
  • • Hyperandrogenism (clinical: hirsutism/acne OR biochemical: raised testosterone/FAI).
  • • Polycystic ovaries on ultrasound.

Management

  • Endometrial Protection: Women with amenorrhoea/oligomenorrhoea (<4 periods a year) are at risk of Endometrial Hyperplasia. Induce a withdrawal bleed at least every 3-4 months using COCP or cyclical progestogens (e.g., Medroxyprogesterone 10mg x 14 days). Mirena IUS is also protective.
  • Metabolic: Screen for Diabetes (HbA1c) and CVD risk. Weight loss is first-line.

7Pelvic Inflammatory Disease (PID)

Infection of the upper genital tract, usually sexually transmitted (Chlamydia/Gonorrhoea) but can be non-STI.

Features

Bilateral pelvic pain, deep dyspareunia, abnormal discharge, PCB/IMB.

Examination

Cervical motion tenderness ("cervical excitation") and adnexal tenderness.

Treatment

Low threshold for antibiotic treatment to prevent fertility/tubal damage.

  • Regimen: IM Ceftriaxone (stat) + Doxycycline (14 days) + Metronidazole (14 days).
  • Partner notification and STI screening essential.

8Urinary Incontinence and Prolapse

Differentiate between Stress and Urge incontinence.

Visual explanation

Stress and urge leakage: two different mechanisms

Simplified bladder diagrams: external pressure with reduced outlet support illustrates stress leakage; contraction of the bladder muscle illustrates a common mechanism of urge leakage.

Stress incontinence

Pressure from coughing, sneezing or exertion overcomes the ability of the urethra to stay closed.

Urge incontinence

Leakage follows a sudden, compelling need to pass urine; involuntary bladder muscle contraction is a common mechanism.

Remember: Stress here means physical pressure. Ask what happens just before the leakage. Stress and urge symptoms can occur together as mixed incontinence.

Simplified illustration, not to scale. Sources: NHS: causes of urinary incontinence

Stress Incontinence

Leakage on effort/exertion (cough, sneeze, jump).

Management: Pelvic Floor Muscle Training (PFMT) - supervised for 3 months. Duloxetine is second-line (specialist initiation usually).

Urge Incontinence (Overactive Bladder)

Sudden compelling desire to pass urine.

Management: Bladder training (drills) for 6 weeks. Caffeine reduction. Anticholinergics (e.g., Oxybutynin, Tolterodine) or Beta-3 agonists (Mirabegron). Caution with anticholinergics in elderly (cognitive burden).

Prolapse

"Dragging" sensation, lump at introitus. Manage with PFMT, weight loss, topical oestrogen (if atrophy), pessaries, or surgery.

9Gynaecological Cancers: Red Flags

Crucial 2-Week Wait (2WW) referral criteria.

Ovarian Cancer

Persistent bloating, early satiety, pelvic pain, urinary urgency/frequency (especially >50). Measure CA125. If raised → Ultrasound → 2WW.

Endometrial Cancer

Post-menopausal bleeding (PMB) is the cardinal red flag. Refer all PMB >55 years on 2WW. (Also consider if <55 with risk factors/persistent irregular bleeding).

Cervical Cancer

Unexplained cervical mass or ulceration.

Vulval Cancer

Unexplained vulval lump or ulceration.

10Breast Disorders: Benign vs Malignant

Most presentations are benign, but cancer must be excluded.

2-Week Wait Referral

  • • Aged >30 with unexplained breast lump (painful or painless).
  • • Aged >50 with unilateral nipple changes (discharge, retraction).
  • • Skin changes (peau d'orange, tethering).
  • • Axillary lump >30.

Benign Conditions

  • Fibroadenoma: "Breast mouse", mobile, firm, smooth. Common in younger women (<30).
  • Cysts: Smooth, fluid-filled.
  • Mastalgia (Breast Pain): Cyclical vs Non-cyclical. Usually managed conservatively (well-fitting bra, topical NSAIDs). Alone, rarely cancer.